Abstract
BackgroundKnee osteoarthritis (OA) has been the main cause behind chronic pain and disabilities in the elderly population. The traditional treatment for knee OA pain currently concerns a number of combinations of pharmacological and nonpharmacological therapies. However, such combinations have displayed little effects on a significant group of subjects. In addition to this, pharmacological treatments often cause adverse effects, which limits their use on this population. Previous studies showed that chronic knee OA pain may be associated with maladaptive compensatory plasticity in pain-related neural central circuits indexed by a defective descending pain-inhibitory system. Transcranial direct current stimulation (tDCS) can revert some of these maladaptive changes, thus decreasing chronic pain sensation. Numerous studies have demonstrated that the use of anodal tDCS stimulation over the primary motor cortex (M1) has positive effects on chronic neuropathic pain. Yet, data on OA pain in elderly patients, including its effects on the endogenous pain-inhibitory system, remain limited.ObjectiveThe objective of this study is to evaluate the efficacy of tDCS in reducing pain intensity caused by knee OA in elderly subjects with defective endogenous pain-inhibitory systems.MethodsWe designed a randomized, sham-controlled, single-center, double-blinded clinical trial. Patients with knee OA who have maintained a chronic pain level during the previous 6 months and report a pain score of 4 or more on a 0-10 numeric rating scale (NRS) for pain in that period will undergo a conditioned pain modulation (CPM) task. Participants who present a reduced CPM response, defined as a decrease in NRS during the CPM task of less than 10%, and meet all of the inclusion criteria will be randomly assigned to receive 15 sessions of 2 mA active or sham tDCS for 20 minutes. A sample size of 94 subjects was calculated. The Brief Pain Inventory pain items will be used to assess pain intensity as our primary outcome. Secondary outcomes will include pain impact on functioning, mobility performance, quality of life, CPM, pressure pain threshold, touch-test sensory evaluation, and safety. Follow-up visits will be performed 2, 4, and 8 weeks following intervention. The data will be analyzed using the principle of intention-to-treat.ResultsThis study was approved by the institutional review board with the protocol number 1685/2016. The enrollment started in April 2018; at the time of publication of this protocol, 25 subjects have been enrolled. We estimate we will complete the enrollment process within 2 years.ConclusionsThis clinical trial will provide relevant data to evaluate if anodal tDCS stimulation over M1 can decrease chronic knee OA pain in elderly subjects with defective CPM. In addition, this trial will advance the investigation of the role of central sensitization in knee OA and evaluate how tDCS stimulation may affect it.Trial RegistrationClinicalTrials.gov NCT03117231; https://clinicaltrials.gov/ct2/show/NCT03117231 (Archived by WebCite at http://webcitation.org/73WM1LCdJ)International Registered Report Identifier (IRRID)RR1-10.2196/11660
Highlights
Osteoarthritis (OA) is the most common cause of pain and disabilities in elderly populations, and the knee is the most commonly affected joint [1,2]
We estimate we will complete the enrollment process within 2 years. This clinical trial will provide relevant data to evaluate if anodal Transcranial direct current stimulation (tDCS) stimulation over M1 can decrease chronic knee OA pain in elderly subjects with defective conditioned pain modulation (CPM)
This trial will advance the investigation of the role of central sensitization in knee OA and evaluate how tDCS stimulation may affect it
Summary
Osteoarthritis (OA) is the most common cause of pain and disabilities in elderly populations, and the knee is the most commonly affected joint [1,2]. OA knee pain is traditionally managed with a combination of pharmacological and nonpharmacological therapies including weight loss, physical therapy, several exercise modalities, anti-inflammatory drugs, topical agents, and opioids analgesics [6]. These treatments can decrease the pain intensity, they can lead to substantial adverse effects (eg, dizziness, dry mouth, constipation, and nausea), and the treatment benefits may decrease over time (eg, opioid tolerance development) [7,8,9]. The traditional treatment for knee OA pain currently concerns a number of combinations of pharmacological and nonpharmacological therapies Such combinations have displayed little effects on a significant group of subjects. Data on OA pain in elderly patients, including its effects on the endogenous pain-inhibitory system, remain limited
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
